Morgan Stanley lowers Kweichow Moutai target price, but maintains Overweight view

Overview

This report is Morgan Stanley's risk-reward update on Kweichow Moutai Company Ltd. (600519.SS). After the release of 2025 results, the report adjusts earnings forecasts and valuation scenarios, lowers the target price and bull/bear scenario prices, but maintains a positive view on the company's relative returns.

Core views

The core view is: short-term demand and volume assumptions have weakened, especially as non-Feitian premium Moutai and mid-to-low-end/non-core SKUs drag on volume forecasts; the Feitian Moutai price increase from March 31, 2026 drives an ASP upgrade, but is not enough to fully offset volume and expense pressure. As the company shifts toward more market-oriented channel management, the selling expense ratio may rise. Nevertheless, the report believes Moutai still has a healthy channel structure, strong brand power, and high earnings visibility.

Analysis framework

The report evaluates the stock's risk-reward through earnings forecast revisions, DCF valuation, bull/bear scenario analysis, EPS and consensus comparisons, breakdowns of key operating drivers, and a risk-reward chart. Valuation mainly centers on 2026e EPS multiples and DCF assumptions, and the target price is assessed in combination with changes in volume, ASP, selling expenses, and capex.

Methodology notes

• Valuation methodsdiscounted_cash_flow

  DCF valuation

  The base target price uses a DCF method, with key assumptions including an 11% WACC, a 3% risk-free rate, a 9.8% risk premium, and a 2% long-term growth rate.

• scenario_analysisbull_base_bear

  bull/bear scenario analysis

  The bull case uses 31x 2026e EPS, corresponding to Rmb2,100; the base case uses 24x 2026e EPS, corresponding to Rmb1,678; the bear case uses 18x 2026e EPS, corresponding to Rmb968.

• earnings_modelMorgan Stanley ModelWare

  earnings forecast model

  The report states that unless otherwise noted, relevant metrics are based on the Morgan Stanley ModelWare framework, and EPS uses a consensus methodology basis.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• 600519.SS

  covered stock

  Strengths

  The channel structure is viewed as one of the healthiest in the industry; brand positioning is strong; 2026e P/E is about 20x, and PEG is about 3.5x based on a 6% earnings CAGR in 2025-2027; the target price still has upside versus the current price.

  Weaknesses

  2026-2027 EPS was lowered by 8%-9%; volume assumptions were reduced, especially for non-Feitian premium Moutai and mid-to-low-end/non-core SKUs; market-oriented channel management may push up the selling expense ratio.

  Comparison

  Morgan Stanley's target price of Rmb1,678 is below the illustrated consensus average of Rmb1,822.67, but the rating remains Overweight; 94% of consensus ratings are Overweight.

  Risks

  Premium baijiu volume growth is below expectations, Moutai wholesale and retail prices continue to fall, and series baijiu remains weaker than expected after increased investment.

Key data

• target price adjustmentRmb1,790.00 -> Rmb1,678.00Lowered by 6%, with the earnings downgrade partly offset by lower capex estimates.
• bull case scenarioRmb2,236.00 -> Rmb2,100.00Corresponds to a recovery in premium brand volume and mid-tier brand sales beating expectations.
• bear case scenarioRmb1,033.00 -> Rmb968.00Corresponds to a delayed recovery in premium brand volume and increased SG&A investment with limited effect.
• 2026e EPSRmb68.98The previous forecast was Rmb74.83.
• 2027e EPSRmb73.58The previous forecast was Rmb80.77.
• 2028e EPSRmb82.56The report newly introduces a 2028e EPS forecast, while the main text mentions about Rmb82.3.
• 2026e Moutai volume growth0.9%Data from the key earnings drivers table.
• 2026e Moutai ASP growth6.2%Affected by the Feitian Moutai price increase.
• 2026e total baijiu volume growth-4.0%Reflects pressure on total volume assumptions.
• 2026e total baijiu ASP growth8.7%Price factors partly offset volume pressure.
• consensus rating distribution94% Overweight, 6% Equal-weight, 0% UnderweightFrom the consensus rating distribution table in the report.
• main revenue region90%-100% Mainland ChinaThe chart shows revenue mainly comes from Mainland China.

Impact & implications

The target price and EPS downgrades indicate cooling short-term growth expectations, shifting the investment case from simple price increases and brand premiums toward tests of volume recovery, channel health, and the efficiency of expense investment. Maintaining Overweight shows that Morgan Stanley still believes Moutai has defensive qualities and re-rating potential relative to the industry, but upside depends more on a recovery in premium baijiu demand, a rebound in wholesale prices, and delivery on channel expansion for series baijiu.

Risks

• Premium baijiu volume growth is below expectations.
• Moutai wholesale and retail prices continue to fall.
• Series baijiu remains weaker than expected after Moutai increases investment.
• A higher selling expense ratio may compress earnings leverage.
• If the recovery in premium consumption is delayed, the bull case scenario will be difficult to realize.

What to watch

• Kweichow Moutai annual general meeting from May 19 to 23, 2026.
• Changes in ASP and channel inventory after the Feitian Moutai price increase.
• Whether premium Moutai volume recovers, and whether non-Feitian products continue to drag.
• Channel expansion for series baijiu and the conversion efficiency of marketing investment.
• Whether Moutai wholesale prices, retail prices, and market sentiment rebound more quickly.
• The impact of company capex expectations and free cash flow on DCF valuation.